Covered recipient · General Payments record
BENJAMIN B BRIDGES
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$3,082.20
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,975.50 | 72 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $264.43 | 6 |
| ABBVIE INC. | $198.25 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $134.01 | 7 |
| GlaxoSmithKline, LLC. | $119.22 | 4 |
| Merck Sharp & Dohme Corporation | $115.41 | 5 |
| Daiichi Sankyo Inc. | $114.70 | 4 |
| Intera Oncology, Inc | $114.21 | 1 |
| Janssen Biotech, Inc. | $99.32 | 3 |
| PFIZER INC. | $86.52 | 4 |
| E.R. Squibb & Sons, L.L.C. | $76.03 | 3 |
| Incyte Corporation | $73.41 | 3 |
| Celgene Corporation | $65.25 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $54.90 | 2 |
| Astellas Pharma US Inc | $46.54 | 2 |
| Lilly USA, LLC | $42.38 | 2 |
| Genentech USA, Inc. | $38.33 | 2 |
| Invivyd Inc | $35.07 | 1 |
| JAZZ PHARMACEUTICALS INC. | $31.85 | 1 |
| TAIHO ONCOLOGY, INC. | $29.83 | 1 |
| Alexion Pharmaceuticals, Inc. | $29.68 | 1 |
| AVEO Pharmaceuticals, Inc. | $27.76 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.60 | 1 |
| Kyowa Kirin, Inc. | $22.76 | 1 |
| Spectrum Pharmaceuticals Inc. | $21.74 | 1 |
| Blueprint Medicines Corporation | $20.81 | 1 |
| Gilead Sciences, Inc. | $20.54 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.49 | 1 |
| SOBI, INC | $18.90 | 1 |
| Acrotech Biopharma Inc. | $13.84 | 1 |
| Coherus Biosciences Inc. | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (72)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.